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Schizogyne sericea (Asteraceae) is a halophytic shrub endemic to the Canary Islands and traditionally employed as
analgesic, astringent, anti-inflammatory, and vulnerary. A comprehensive phytochemical investigation was conducted on the
flowering aerial parts by analyzing both essential oil constituents and polar compounds. The essential oil was dominated by p-
cymene, with the noteworthy occurrence of b-pinene and thymol esters. From the EtOH extract, eight compounds were
isolated and structurally elucidated. Essential oil, polar fractions, and isolates (2), (4), and (5) were separately in vitro assayed
for antiproliferative activity on human tumor cell lines (A375, MDA-MB 231, and HCT116) by MTT assay, for antioxidant
potential by DPPH, ABTS, and FRAP assays, and for antimicrobial activity by the agar disk diffusion method. Results
revealed that essential oil and compounds 1 and 2 exert a strong inhibition on tumor cells, and in some cases, higher than that
of cisplatin. Fractions containing thymol derivatives (1 and 2) and caffeoylquinic acid derivatives 4 and 5 displayed
antioxidant activity comparable to that of Trolox, making S. sericea extract an interesting natural product with potential
applications as preservative or in the treatment of diseases in which oxidative stress plays an important role.
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Introduction
The genus Schizogyne CASS., one of the three genera of
the tribe Inulae of the family Asteraceae (subfamily
Asteroideae), is endemic to the Selvagens and Canaries,
which are Macaronesian Islands [1] and consists of two
halophytic species: S. glaberrima DC. and S. sericea
(L.F.) DC. These species differ in the hairiness and
shape of leaves and also in their distribution, the former
being endemic to Gran Canaria (Canary Islands) and
the latter widespread in all the Canary and Selvagem
Islands.
S. sericea (syn. Chrysocoma sericea L.F., Inula schizog-
yne MASF.), well-known as ‘salado’, is a shrub up to 1 m
tall, with silky stems and leaves, the latter being linear,
flat, 3 – 5 cm wide, obtuse, and white-grayish. Inflores-
cences are yellow capitula without ray florets. S. sericea is
widespread in rocky coastal regions throughout all the
Canary Islands, being more common in Tenerife and
Gran Canaria [2].
In the folk medicine, the whole plant or the top flow-
ering aerial parts were used in infusion as analgesic,
astringent, anti-inflammatory, and vulnerary. Moreover,
the plant is given to goats as forage [3].
From Schizogyne species a series of thymol derivatives
was previously isolated and structurally elucidated, among
which 10-acetoxy-8-hydroxy-9-isobutyryloxy-6-methoxy-
thymol was shown to exert anti-inflammatory activity on
carrageenan-induced edema in rats [4][5][6]. As far as the
volatile fraction is concerned, only S. glaberrima was stud-
ied for the essential oil composition [7], whereas S. sericea
has not been previously investigated.
In the present work, we carried out a comprehen-
sive phytochemical analysis on both polar compounds
and essential oil constituents obtained from the flower-
ing aerial parts of S. sericea which were analyzed by
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NMR, and GC and GC/MS, respectively. The main
compounds isolated from the EtOH extracts as well as
the hydrodistilled essential oil were assayed for in vitro
biological activity. In particular, the antioxidant activi-
ties were studied by DPPH (for free-radical scavenging
activity), ABTS (for total radical scavenging capacity),
and FRAP assay (for determination of antioxidant
power); the antimicrobial activities were examined by
agar disk diffusion; and the cytotoxicity on tumor cells
was explored by MTT assay.
Results and Discussion
Essential Oil Analysis
A total of 62 volatile components, accounting for 89.6%
of the total composition, were identified in the essential
oil from S. sericea (Table 1). The majority of them belong
to the group of monoterpenes (86.1%) and, to a minor
extent, to sesquiterpenes (3.1%). Notably, in the mono-
terpene fraction the aromatic compounds represented the
major group (54.8%), with the hydrocarbon p-cymene as
the most representative (45%). Among them, noteworthy
was the presence of thymol derivatives (9.8%) such as
8,9-dehydrothymol isobutyrate (2.8%) and thymol iso-
butyrate (3.2%). These compounds are of chemotaxo-
nomic interest since they were found also in the essential
oil of S. glaberrima from Gran Canaria [7] and in other
Asteraceae such as Arnica amplexicaulis NUTT. (syn. of
A. lanceolata subsp. prima (MAGUIRE) STROTHER & S.J.
WOLF) and Carpesium divaricatum SIEBOLD & ZUCC. [8]
[9]. In addition, we identified other thymol derivatives
which were not found in the essential oil of S. glaberrima
but in its EtOH extract such as 10-acetoxy-8,10-dehydro-9-
isobutyryloxy-6-methoxythymol (0.8%) and 10-acetoxy-
8,10-dehydro-9-isobutyryloxy-6-methoxythymol (1.4%) [4].
The second group of monoterpenes was made-up of
hydrocarbons (22.1%), with b-pinene (6.0%), limonene
(4.8%), camphene (4.8%), and a-phellandrene (4.4%) as
the most abundant. Finally, the third group of monoter-
penes consisted of oxygenated compounds (9.2%), which
were represented mainly by isobornyl acetate (5.3%).
Among sesquiterpenes, there were no components
exceeding 1%.
Although several reports on the thymol derivatives
have been published [5][6], the composition and biological
activities of the essential oil of S. sericea are herein
reported for the first time. Our results showed that its
volatile chemical profile was qualitatively similar to that
found for S. glaberrima from Gran Canaria, which con-
tained p-cymene (64.9%), limonene (25.2%), and a-phel-
landrene (5.2%) as the major constituents [7]. Among
other components, camphene (0.3%), b-pinene (0.3%),
isobornyl acetate (0.1%), 8,9-dehydrothymol isobutyrate
(1.0%), and thymol isobutyrate (0.9%) were found here
at lower levels. Another difference between S. sericea and
S. glaberrima was given by the number of essential oil
components detected (62 vs. 29, respectively). We assume
that the aforementioned differences can be attributed to
genetic factors (i.e., different species), geographic origin
(Tenerife vs. Gran Canaria), microclimate, and harvesting
period (September vs. April). Also, a different sensitivity
in the GC method used may have influenced the results.
Polar Compounds
The analysis of the polar fraction led to the identification of
several phenolic compounds (1 – 8, Fig. 1). In particular,
the thymol derivatives, 2-{2-[(acetyloxy)methyl]oxi-
ran-2-yl}-5-methylphenyl 2-methylpropanoate (1), 2-{2-
[(acetyloxy)methyl]oxiran-2-yl}-4-methoxy-5-methylphenyl
2-methylpropanoate (2), and 3-(acetyloxy)-2-hydroxy-2-(2-
hydroxy-5-methoxy-4-methylphenyl)propyl 2-methylpro-
panoate (3), were identified. Compound 2, firstly isolated
from Ageratina glabrata (KUNTH) R.M.KING & H.ROB.
(Asteraceae) [8], and compound 3 were previously identi-
fied in this species as well as in S. glaberrima [4][5].
It is worth noting that compound 2-{2-[(acetyloxy)
methyl]oxiran-2-yl}-5-methylphenyl 2-methylpropanoate
(1) is reported for the first time in Schizogyne. This com-
pound was first identified in Wedelia forsteriana ENDL.
[16]. Afterwards, it was found in the genera Ageratina,
Critonia, Fleischmannia [17], and Leontonyx [18], all
included in the family Asteraceae, thus demonstrating
their taxonomical proximity. It should be mentioned that
compound 1 is believed to be responsible for allergic phe-
nomena of contact dermatitis caused by Arnica sachali-
nensis (REGEL) A.GRAY (Asteraceae) [19][20]. In
addition, five phenolic acids, namely 3,5-dicaffeoylquinic
acid (4), 1,3-dicaffeoylquinic acid (5), 3-caffeoylquinic
acid (chlorogenic acid) (6), 4-caffeoylquinic acid (cryp-
tochlorogenic acid) (7), and caffeic acid (8), were recog-
nized for the first time in this species. These
caffeoylquinic acid derivatives are endowed with interest-
ing biological activities, e.g., antioxidant [21][22] and hep-
atoprotective [23]. From the chemotaxonomical point of
view, these phenolic compounds are highly distributed in
the Asteraceae family. In particular, compounds 4 and 5
are constituents of Achillea millefolium L. [24] and
together with caffeic (8) and caffeoylquinic acids (6, 7)
are present in the leaves of Cynara syriaca BOISS. [25].
Chlorogenic acid (6) was found to be a constituent of sev-
eral species of the genus Crepis [26], Baccharis retusa
DC. [27], and together with 3,5-dicaffeoylquinic acid (4)
was found in other Asteraceae such as Arnica montana
L., Artemisia vulgaris L., Calendula officinalis L., and
Chamomilla recutita (L.) RAUSCHERT [22].
Antioxidant Activity
The free-radical scavenging activity of essential oil and
polar compounds from S. sericea was analyzed by three
different in vitro assays, namely DPPH, ABTS, and
FRAP, and results are presented in Table 2. The essential
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Table 1. Chemical composition of the essential oil from the aerial parts of Schizogyne sericea
No. Componenta) LRIb) LRI litc) %d) IDe)
ADAMS NIST 08
1 a-Thujene 917 924 917 trf) RI, MS
2 a-Pinene 921 932 922 0.9 Std
3 Camphene 934 946 935 4.8 Std
4 Sabinene 961 969 961 0.1 RI, MS
5 b-Pinene 962 974 962 6.0 Std
6 Myrcene 983 988 983 0.2 Std
7 d-2-Carene 993 1001 993 tr RI, MS
8 a-Phellandrene 997 1002 998 4.4 Std
9 d-3-Carene 1001 1008 1001 tr Std
10 a-Terpinene 1010 1014 1010 0.1 RI, MS
11 p-Cymene 1019 1020 1018 45.0 Std
12 Limonene 1021 1024 1021 4.8 Std
13 (E)-b-Ocimene 1043 1044 1043 0.1 RI, MS
14 c-Terpinene 1051 1054 1051 tr Std
15 Terpinolene 1080 1086 1080 0.4 Std
16 p-Cymene 1088 1089 tr RI, MS
17 Linalool 1097 1095 1097 tr Std
18 (E)-4,8-Dimethyl-1,3,7-nonatriene 1112 1106g) 0.2 RI, MS
19 cis-p-Menth-2-en-1-ol 1113 1118 0.2 RI, MS
20 trans-p-Menth-2-en-1-ol 1132 1136 0.1 RI, MS
21 Camphor 1134 1141 1136 tr Std
22 Camphene hydrate 1136 1145 1136 0.1 RI, MS
23 Isoborneol 1155 1155 0.1 Std
24 Terpinen-4-ol 1168 1174 1169 0.1 Std
25 Dill ether 1181 1184 0.1 RI, MS
26 a-Terpineol 1182 1186 1182 0.1 Std
27 cis-Piperitol 1187 1195 1187 0.1 RI, MS
28 trans-Piperitol 1200 1207 1201 0.1 RI, MS
29 Coahuilensol, methyl ether 1220 1221h) 1.2 RI, MS
30 Piperitone 1246 1249 1247 0.1 RI, MS
31 Isobornyl acetate 1276 1283 1277 5.3 Std
32 Lavandulyl acetate 1288 1288 0.5 RI, MS
33 Thymol 1291 1289 1291 0.1 Std
34 Myrtenyl acetate 1317 1324 1316 tr RI, MS
35 d-Elemene 1325 1335 1327 tr RI, MS
36 Neryl acetate 1360 1359 1360 1.1 Std
37 b-Elemene 1380 1389 1381 tr RI, MS
38 Cyperene 1385 1398 1385 tr RI, MS
39 Methyl eugenol 1400 1403 1400 0.3 RI, MS
40 Cuminyl acetate 1409 1409 0.2 RI, MS
41 Isobornyl isobutanoate 1431 1431 0.8 RI, MS
42 a-Humulene 1437 1452 1440 0.1 Std
43 8,9-Dehydrothymol isobutyrate 1456 1456 2.8 RI, MSi)
44 Thymol isobutyrate 1460 1460 3.2 RI, MSi)
45 Germacrene D 1465 1484 1466 0.1 RI, MS
46 a-Selinene 1481 1498 1481 tr RI, MS
47 Bicyclogermacrene 1481 1500 1482 0.3 RI, MS
48 Neryl isobutyrate 1486 1490 1487 0.3 RI, MS
49 a-Muurolene 1487 1500 1488 0.1 RI, MS
50 d-Cadinene 1510 1523 1511 0.3 RI, MS
51 (E)-Nerolidol 1556 1561 1556 0.3 Std
52 Spathulenol 1572 1577 1572 0.4 RI, MS
53 Neryl isovalerate 1580 1582 0.1 RI, MS
54 b-Oplopenone 1596 1607 1596 0.1 RI, MS
55 epi-a-Cadinol 1635 1638 0.6 RI, MS
56 epi-a-Muurolol 1639 1640 0.5 RI, MS
57 a-Cadinol 1640 1652 1640 0.6 RI, MS
58 6-Methoxythymol isobutyrate 1671 1671 0.1 RI, MSi)
59 Unknownj) 1790 2.9
60 Unknownj) 1903 1.3
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oil showed a weak antioxidant capacity, with TEAC val-
ues of 43.7 and 39.6 lmol TE/g toward DPPH and ABTS,
respectively, and a TEAC value of 66.2 lmol TE/g in the
FRAP assay. This weak free-radical scavenging capacity
may be in part attributed to one of its main components,
p-cymene. This aromatic monoterpene has been reported
to exhibit low antioxidant activity in vitro [28], but high
antioxidant potential in vivo and may act as a neuro-
protective agent in the brain [29].
However, the caffeoylquinic acid derivatives com-
pound 4 and 5, showed significant antioxidant activity in
the three different assays tested, which is in good agree-
ment with the results obtained in previous work [30][31]
[32]. Although both compounds exhibited similar metal
Fig. 1. Structures of compounds isolated from the polar fraction of Schizogyne sericea.
Table 1. (cont.)
No. Componenta) LRIb) LRI litc) %d) IDe)
ADAMS NIST 08
61 10-Acetoxy-8,9-dehydro-6-methoxythymol isobutyrate 1984 0.8 MSk)
62 10-Acetoxy-8,10-dehydro-9-isobutyryloxy-6-methoxythymol 2084 1.4 MSk)
63 10-Acetoxy-8,9-epoxy-2-methoxythymol 2116 tr MSk)
64 Abienol 2148 2149 0.3 RI, MS
Oil yield (%) 1.7
Total identified (%) 89.6
Grouped compounds
Aromatic monoterpenes 54.8
Monoterpene hydrocarbons 22.1
Oxygenated monoterpenes 9.2
Sesquiterpene hydrocarbons 0.8
Oxygenated sesquiterpenes 2.3
Others 0.4
a) Compounds are listed in order of their elution from a HP-5MS column. b) Linear retention index on HP-5MS column, experimentally deter-
mined using homologous series of C8 – C30 alkanes.
c) Relative retention index taken from Adams [10] and FFNSC2 [11] for apolar capillary
column. d) Percentage values are means of three determinations, with a RSD% for the main components below 5% in all cases. e) Identification
methods: MS, by comparison of the mass spectrum with those of the computer mass libraries Wiley, Adams, FFNSC2, and NIST 08; RI, by com-
parison of RI with those reported in the literature [10 – 12]; Std, by comparison of the retention time and mass spectrum of available authentic
standard or. f) Tr, traces (mean value below 0.1%). g) Retention index value taken from Vichi et al. [13]. h) Retention index value taken from
Venditti et al. [14]. i) RIs and MS fragmentations according to Weyerstahl et al. [15]. j) MS data for unidentified components: RI 1790 m/z
(%) = 276(4, M+), 148(100), 146(87), 145(84), 43(73), 135(46), 71(30), 133(30), 206(24), 147(17), 149(14); RI 1903 m/z (%) = 276(1, M+), 149
(100), 43(97), 162(77), 145(62), 71(46), 161(39), 133(31), 150(24), 135(21), 146(19). k) MS fragmentations according to Gonzalez et al. [4][5].
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ion chelating activity in the FRAP assay (TEAC values in
the range of 803.1 – 803.5 lmol TE/g), compound 4
showed higher radical scavenging activity toward DPPH
and ABTS radicals with TEAC values of 1468 and
1720 lmol TE/g, respectively, when compared to com-
pound 5 (728 and 942 lmol TE/g, respectively). High
antioxidant activity was previously reported for the thy-
mol derivatives compound 1 and 2 [33][34]. In our assays,
these molecules were tested as such (2) or as a mixture
containing them (1 + 2) in different ratios. The fraction
containing compounds 1 and 2 (1:2) showed the highest
radical scavenging activity, with TEAC values of
2864 lmol TE/g and 4564 lmol TE/g toward DPPH and
ABTS radicals, respectively, and a TEAC value of
850 lmol TE/g in the FRAP assay (Table 2).
The good antioxidant activity displayed by S. sericea
fractions and isolated compounds may support the tradi-
tional uses of the plant in the Canary Islands in the treat-
ment of diseases, such as inflammations and wounds, in
which oxidative stress plays an important role. In addi-
tion, these properties may be exploited also at industrial
level in the manufacturing of food preservatives.
Cytotoxic Activity
The cytotoxic activity of S. sericea essential oil was evalu-
ated on human tumor cell lines: A375 human malignant
melanoma cell line, MDA-MB 231 human breast adeno-
carcinoma cell line, and HCT116 human colon carcinoma
cell line by MTT assay. All cell lines were subjected to
increasing concentrations of essential oil for 72 h. The
results, collected in Table 3, show that essential oil exhib-
ited a significant cytotoxic activity against the human
cancer cells examined and induced a concentration-depen-
dent inhibitory effect in the dilutions ranging from 0.8 to
200 lg/ml. The IC50 values of the essential oil were 3.5,
6.6, and 3.4 lg/ml for A375, MDA-MB 231, and HCT116
cell lines, respectively. In literature, the main compound
of the essential oil, p-cymene (40.8%), is reported to have
low cytotoxic activity on two tumor cell lines, A-549 lung
carcinoma cells and DLD-1 colon adenocarcinoma cells
[35]. This compound is highly hydrophobic and causes
swelling of the cytoplasmic membrane [36]. Being easily
incorporated in the lipid bilayer, it may facilitate trans-
port of other effective active compounds. Among them,
thymol derivatives might contribute to the cytotoxic activ-
ity or be responsible for synergism together with other
compounds. Notably, 8,9-dehydrothymol isobutyrate is
reported to be a component of a pharmaceutical formula-
tion patented as anticancer agent [9].
Fractions and isolated compounds were investigated
for their cytotoxic activity (Table 3) against the same
human tumor cell lines. Data show highly significant
antiproliferative activity for compound 2, with IC50 values
of 0.5 (1.4 lM), 0.5 (1.5 lM), and 1.2 (3.6 lM) lg/ml
toward MDA-MB 231, A375, and HCT116 cell line,
respectively. Compound 1 mixed with compound 2
showed a minor effect on tumor cells. These data agree
with those reported in literature by Aponte et al. [37]
where compound 2 and 3 were isolated from Mika-
nia decora POEPP. and exhibited significant cytotoxic activ-
ity against a panel of human tumor cell lines. The authors
supposed that the cytotoxic activity was due to the pres-
ence of the 8,9-epoxy-10-acetoxy groups. Analogous thy-
mol derivatives showed similar cytotoxic activity [9]. As
regards compounds 4 and 5, they showed low cytotoxic
effects against all tumor cell lines tested. Puangpraphant
et al. [38] reported that dicaffeoylquinic acids isolated
from Ilex paraguariensis induced apoptosis by increasing
the activation of caspase-8 in both RKO and HT-29 colon
cancer cells, but with IC50 values higher than those
obtained in our experiments.
Antimicrobial Activity
Table 4 shows the results of the antimicrobial activity of
S. sericea essential oil by the disk diffusion method. We
found that the antimicrobial activity of the essential oil
Table 2. In vitro radical scavenging activities of essential oil, fractions and isolated compounds from Schizogyne sericea
Schizogyne sericea DPPH ABTS FRAP
TEACa) IC50
b) TEACa) IC50
b) TEACa)
[lmol TE/g] [lg/ml] [lmol TE/g] [lg/ml] [lmol TE/g]
Essential oil 43.7  3.5 391  31 39.6  1.3 150  4.9 66.2  3.5
Fractions
Compounds 1 + 2 (1:1) 196  6.5 71.0  2.4 363  12.1 23.1  0.8 568  6.6
Compounds 1 + 2 (1:2) 2864  97.0 4.9  0.2 4564  360.4 1.8  0.1 850  43.3
Isolated compounds
Compound 2 249  19.7 56.1  4.4 1471  8.7 5.7  0.0 775  13.3
Compound 4 1468  45.5 9.5  0.3 1720  165.7 4.9  0.5 803  32.2
Compound 5 728  10.1 19.2  0.3 942  20.3 8.9  0.2 803  5.3
Positive control
Trolox 3.5  0.2 2.1  0.0
a) TEAC = Trolox equivalent (TE) antioxidant concentration. b) IC50 = The concentration of compound that affords a 50% reduction in the
assay.
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on the growth of bacterial pathogens was positive, albeit
low, toward Staphylococcus aureus and Escherichia coli
strains, but was ineffective in the case of Enterococcus
faecalis and Pseudomonas aeruginosa. Hence, it could
be observed that this activity did not correlate with the
subdivision of bacteria into Gram-positives and Gram-
negatives. Nevertheless, E. faecalis and P. aeruginosa are
well-known for their natural resistance to many
antibiotics. However, antifungal activity against Candida
albicans was also found (8.5 mm inhibition zone
diameter).
The low or no antimicrobial activity showed by the
essential oil against the test organisms considered may be
explained by the presence of p-cymene, one of the main
constituents, that has been described as nonactive [39].
Nevertheless, p-cymene is able to increase cell membrane
permeability toward other compounds (e.g., carvacrol),
which are then favored in exerting their intrinsic antimi-
crobial activity [40]. In this respect, we have to mention
that carvacrol or similar compounds were not present in
the essential oil investigated. Other representative compo-
nents, such as limonene, camphene, b-pinene, and isobor-
nyl acetate, have been reported to have low or no activity
in antimicrobial susceptibility testing [41]. All these data
together may well explain the overall activity measured
for S. sericea essential oil in the present work.
Activity of fractions and isolated compounds were in
the range of 6.0 (no activity) to 10.0 mm (low activity)
inhibition zone diameter. 2-{2-[(acetyloxy)methyl]oxiran-
2-yl}-4-methoxy-5-methylphenyl 2-methylpropanoate (2)
was undoubtedly the most active compound. All microbial
species were affected by compound 2 with inhibition zone
Table 3. In vitro cytotoxic activity of essential oil, fractions and isolated compounds from Schizogyne sericea
Schizogyne sericea Cell line [IC50 lg/ml]
a)
A375b) MDA-MB 231c) HCT116d)
Essential oil 3.5 6.6 3.4
95% C.I.e) 3.1 – 4.0 6.1 – 7.2 3.0 – 3.8
Fractions
Compounds 1 + 2 (1:1) 4.6 7.6 8.3
95% C.I. 3.8 – 5.5 6.7 – 8.7 7.0 – 9.9
Compounds 1 + 2 (1:2) 0.4 1.7 1.3
95% C.I. 0.4 – 0.5 1.6 – 1.8 1.2 – 1.4
Isolated compounds
Compound 2 0.5 0.5 1.2
95% C.I. 0.4 – 0.5 0.4 – 0.5 1.1 – 1.3
Compound 4 > 100 > 100 > 100
Compound 5 > 100 > 100 > 100
Positive control
Cisplatin 0.4 2.9 2.4
95% C.I. 0.3 – 0.5 2.2 – 3.1 2.0 – 2.9
a) IC50 = The concentration of compound that affords a 50% reduction in cell growth (after 72 h of incubation).
b) Human malignant
melanoma cell line. c) Human breast adenocarcinoma cell line. d) Human colon carcinoma cell line. e) Confidence interval.
Table 4. Antimicrobial activity of essential oil, fractions and isolated secondary metabolites from Schizogyne sericea determined by the disk
diffusion. Values indicate the diameter of the growth inhibition zone (mm) around the disk containing the indicated material and are averages
of at least two determinations
Schizogyne sericea S. aureus E. faecalis E. coli P. aeruginosa C. albicans
Essentialoil 11.0  1.0 6.5  0.5 8.0  0.0 6.0  0.0 8.5  0.0
Fractions
Compounds 1 + 2 (1:1) 9.3  1.2 8.2  1.0 8.3  6.6 7.2  1.6 8.8  0.3
Compounds 1 + 2 (1:2) 9.3  0.6 9.2  1.3 8.3  0.6 8.2  0.8 9.0  0.0
Isolated compounds
Compound 2 9.3  1.2 9.0  1.0 9.2  1.0 8.0  1.0 10.0  0.0
Compound 4 8.7  1.5 6.7  1.2 8.0  1.0 6.0  0.0 9.7  0.6
Compound 5 8.8  0.8 7.7  0.6 8.7  0.6 7.5  0.9 8.3  0.6
Reference antibiotics
Ciprofloxacin 22 – 24 n.r.a) 28 – 30 28 – 32 n.r.
Nystatin n.r. n.r. n.r. n.r. 15 – 16
a) n.r.: not recommended for this species.
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diameters above 8 mm. Also E. faecalis and P. aeruginosa
were inhibited to some extent. Compound 2 is also the
main contributor to inhibition of microbial growth
observed for the fractions. Inhibition zone diameters pro-
duced by compound 2, when tested alone, were compara-
ble to those obtained in combination with compound 1
(Table 4, Fractions). Actually, compound 1 seemed to be
inactive. Reduced diameters were obtained by the frac-
tion combining compounds 1 and 2 at 1:1 molar ratio
against all microbes, except for S. aureus, probably due to
a dilution effect on compound 2. Accordingly, once the
relative amount of compound 2 was doubled (fractions
with compounds 1 + 2 at 1:2 molar ratio) the activity was
almost completely restored reaching that of compound 2
alone. Compounds 4 and 5 showed a measurable activity
(inhibition zone diameters 6.0 – 9.7 mm). 3,5-dicaffeoyl-
quinic acid (4) was inhibiting all microorganisms tested,
while 1,3-dicaffeoylquinic acid (5) produced a wider inhi-
bition zone in the yeast than against bacteria, especially
E. faecalis and P. aeruginosa. The results obtained
with phenolic acids agree with previous reports on the
antimicrobial activity by these compounds [42][43].
In conclusion, even if results of tested isolated com-
pounds from polar fractions of S. sericea did not show
potent antimicrobial inhibition, this work provides the
first report on the antibacterial and antifungal activity of
isolated compounds 2-{2-[(acetyloxy)methyl]oxiran-
2-yl}-5-methylphenyl 2-methylpropanoate and 2-{2-[(acet-
yloxy)methyl]oxiran-2-yl}-4-methoxy-5-methylphenyl 2-
methylpropanoate, in addition to that of the essential oil.
Obtained data were not considered sufficiently promising
to deserve further investigation by other susceptibility
testing methods, such as the microdilution method.
Conclusions
This work represented the first phytochemical and biolog-
ical investigation of the essential oil from S. sericea. The
chemical profile evidenced similarities with that already
reported for S. glaberrima. In this regard, the occurrence
of thymol derivatives may be considered of chemotaxo-
nomic interest. These molecules were also found in the
polar fraction and they exhibited a strong cytotoxicity on
tumor cells, thus having promising applications as natural
anticancer agents. In this respect, future studies will be
performed in our group to investigate the cytotoxic mech-
anisms and in vivo antitumor properties of these con-
stituents. Moreover, polar fractions and isolated
constituents obtained from the EtOH extract of S. sericea
displayed a strong antioxidant activity making this plant
an interesting source of natural products with potential
applications as food preservative or in the treatment of
diseases in which oxidative stress plays an important role.
This work was supported by the FAR 2014-2015 (Fondo
di Ateneo per la Ricerca, FPI000044) of the University of
Camerino.
Experimental Part
General
Solvents of RPE grade were purchased from Sigma–
Aldrich (Saint Louis, MO, USA) or Carlo Erba Reagenti
(Milan, Italy), silica gel 60 (70 – 230 mesh ASTM) from
Fluka (Buchs, Switzerland). NMR Spectra: Varian Mer-
cury 300 MHz (now Agilent Technologies, Santa Clara,
CA, USA) and/or on Bruker Avance III 400 MHz instru-
ment (Bruker, Billerica, MA, USA) using CDCl3,
CD3OD, or D2O (Sigma–Aldrich) as deuterated solvents;
d in ppm rel. to Me4Si as internal standard, J in Hz. Inter-
nal solvent signal was used to set spectra in CD3OD (q,
3.31 ppm) and D2O (s, 4.79 ppm). MS: Q-TOF MICRO
spectrometer (Micromass; now Waters, Manchester, UK)
equipped with an ESI source that operated in the nega-
tive and/or positive ion mode; in m/z. The flow rate of
sample infusion was 10 ll/min with 100 acquisitions per
spectrum. Data were analyzed using the MassLynx
software (Waters).
Plant Material
Aerial parts of S. sericea were collected in Monta~na de
Guaza (Tenerife, 428 m, Canary Islands, Spain) during
blooming in September 2013. A voucher specimen of the
plant was deposited with the Herbarium of the University
of La Laguna (identified by Dr. Consuelo Hernandez
Padron, Department of Plant Biology, Tenerife, Spain)
and in the Herbarium Universitatis Camerinensis (included
in the online edition of Index Herbariorum c/o School of
Biosciences and Veterinary Medicine, University of
Camerino, Italy) under the code TFC no. 50941 and
CAME 26323, respectively, and archived and published in
the anArchive system for botanical data (anArchive
system, http://www.anarchive.it). Just after its collection,
plant material was dried in an airy oven at 36 °C; its
storage was at r.t. in darkness.
Essential Oil Isolation
Plant material (180 g) was reduced in small pieces and
then hydrodistilled in a Clevenger-type apparatus using
5 l of distilled water for 3 h until no more volatile oil was
obtained. The essential oil was stored in a sealed vial pro-
tected from light at 20 °C before chemical analysis and
biological assays. The oil yield (1.7%, n = 3) was esti-
mated on a dry weight basis.
GC/FID and GC/MS Analyses
For GC separations, an Agilent 4890D gas chromatograph
coupled to a flame-ionization detector (FID) was used.
Volatile components were separated on a HP-5 capillary
column (5% phenylmethylpolysiloxane, 30 m, 0.32 mm
i.d.; 0.25 mm film thickness; J and W Scientific, Folsom,
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CA, USA), with the following temp. program: 5 min at
60 °C, subsequently 4 °C/min up to 220 °C, then 11 °C/
min up to 280 °C, held for 15 min, for a total run of
65 min. Injector and transfer line temp. were 280 °C; He
was used as the carrier gas, at a flow rate of 1.8 ml/min;
split ratio, 1:34. A mixture of aliphatic hydrocarbons
(C8 – C30; Sigma, Milan, Italy) in hexane was directly
injected into the GC under the above temp. program, in
order to calculate the temp.-programmed RIs of peaks in
the chromatograms. Oil samples were diluted to 1:100 in
n-hexane and injected at a volume of 1 ll. Analysis was
repeated three times for each sample and the mean value
was reported. Data were collected using HP3398A GC
Chemstation software (Hewlett Packard, Rev. A.01.01).
Quantification of essential oil components was achieved
by FID peak-area internal normalization without using
correction factors. GC/MS analysis was performed on an
Agilent 6890N gas chromatograph coupled to a 5973N
mass spectrometer using a HP-5 MS (5% phenyl-
methylpolysiloxane, 30 m, 0.25 mm i.d., 0.1 mm film
thickness; J & W Scientific) capillary column. The temp.
program was the same as described above. Injector and
transfer line temp. were 280 °C; He was used as the car-
rier gas, at a flow rate of 1 ml/min; split ratio, 1:50; acqui-
sition mass range, 29 – 400 m/z. Mass spectra were
acquired in electron-impact (EI) mode with an ionization
voltage of 70 eV. Oil sample was diluted to 1:100 in
n-hexane, and the volume injected was 2 ll. Data were
analyzed using MSD ChemStation software (Agilent,
Version G1701DA D.01.00). Major oil constituents were
identified by coinjection with authentic standards pur-
chased from Sigma–Aldrich (Milan, Italy). Otherwise, the
peak assignment was carried out according to the recom-
mendations of the International Organization of the
Flavor Industry (IOFI, http://www.iofi.org/), i.e., by the
interactive combination of chromatographic linear reten-
tion indices that were consistent with those reported in
literature for apolar stationary phases [10][11][12], and
MS data consisting in the computer matching with the
WILEY275, NIST 08 ADAMS, FFNSC 2, and a home-
made (based on the analyses of reference oils and
commercially available standards) libraries.
Isolation of Compounds
A portion of 122.5 g of dried plant materials (aerial parts)
was extracted three times by maceration for 24 – 48 h,
with an 80% EtOH/H2O solution (800 ml). The three
extracts were gathered, the EtOH was distilled off at
reduced pressure on a rotatory evaporator, and the result-
ing water suspension was lyophilized obtaining 29.0 g of
crude extract. The chromatographic purification, on silica
gel (SiO2) column chromatography (CC), was conducted
on 3.0 g of the crude extract, using BuOH saturated with
H2O as eluent to provide two low polarity fractions;
Fr-2 – Fr-5 and a mixture of waxes, chlorophylls, and
other low polarity components (700.2 mg), (Fr-6)
(86.4 mg) containing compounds 1 and 2 in mixture (1:1),
3,5-dicaffeoylquinic acid 4 (Fr-17) (23.3 mg), and several
polar fractions containing mixtures of caffeoyl derivatives
(5, 6, 7, and 8) which were gathered by similarity in Fr-
13 – Fr-23, excluding Fr-17 (177.6 mg), and Fr-24 – Fr-70
(393.3 mg). Fr-13 – Fr-23 were further purified on a SiO2
CC (4.5 g) eluted using a mixture of CHCl3/MeOH, pre-
viously saturated with CO2, (9:1 – 7:3) to give 1,3-dicaf-
feoylquinic acid 5 (Fr-32) (19.6 mg) and again 3,5-
dicaffeoylquinic acid 4 in mixture 1:2 with cryptochloro-
genic acid 7 (Fr-44 – Fr-50) (6.5 mg). Fraction Fr-24 –
Fr-70 was purified on acidic SiO2 CC (7.0 g) with CHCl3/
MeOH (8:2 – 6:4) to afford caffeic acid 8 (Fr-22)
(8.9 mg), chlorogenic acid (6), and cryptochlorogenic acid
7 (2:1) (Fr-25 – Fr-33) (18.3 mg). The low polarity frac-
tion (Fr-2 – Fr-5) was rechromatographed on SiO2
(35.0 g) with CHCl3/AcOEt (99:1 – 9:1) to give 2-{2-
[(acetyloxy)methyl]oxiran-2-yl}-4-methoxy-5-methylphenyl
2-methylpropanoate 2 (35.5 mg) (Fr-30 – Fr-31) and
3-(acetyloxy)-2-hydroxy-2-(2-hydroxy-5-methoxy-4-methyl-
phenyl)propyl 2-methylpropanoate 3 (3.5 mg) (Fr-
40 – Fr-41).
All the isolated compounds were identified by com-
parison with literature data and/or direct comparison with
standard compounds available in our laboratory.
2-{2-[(Acetyloxy)methyl]oxiran-2-yl}-5-methylphenyl
2-methylpropanoate (1). 1H-NMR (400 MHz, CDCl3):
7.35 (d, J = 8.0, H–C(5)); 7.04 (dd, J = 8.5, 1.6, H–C(6));
6.86 (br. s, H–C(2)); 4.52 (d, J = 12.3, Ha–C(10)); 4.21 (d,
J = 12.2, Hb–C(10)); 3.02 (d, J = 4.3, Ha–C(9)); 2.81 (d,
J = 4.2, Hb–C(9)); 2.34 (s, H–C(7)); 2.01 (s, H–C(12));
1.30 (d, J = 7.0, Me(15,16)). 13C-NMR (75 MHz, CDCl3):
175.8 (C(13)); 170.7 (C(11)); 140.2 (C(3)); 130.4 (C(1));
128.5(C(6)); 126.9 (C(2)); 123.1 (C(5)); 65.6 (C(10)); 57.0
(C(8)); 51.1 (C(9)); 34.4 (C(14)); 21.3 (C(12)); 19.2 (Me
(15)); 19.1 (Me(16)); 14.3 (C(7)). ESI-MS: 315.10
([M+Na]+).
2-{2-[(Acetyloxy)methyl]oxiran-2-yl}-4-methoxy-5-meth-
ylphenyl 2-methylpropanoate (2). 1H-NMR (300 MHz,
CDCl3): 6.89 (s, H–C(5)); 6.80 (s, H–C(2)); 4.55 (d,
J = 12.2, Ha–C(10)); 4.20 (d, J = 12.2, Hb–C(10)); 3.82 (s,
MeO); 3.04 (d, J = 5.3, Ha–C(9)); 2.81 (d, J = 5.3,
Hb–C(9)); 2.80 (q, J = 7.0, H–C(14)); 2.18 (s, H–C(7));
2.03 (s, H–C(12)); 1.30 (d, J = 7.0, Me(15,16)). 13C-NMR
(75 MHz, CDCl3): 175.8 (C(13)); 170.5 (C(11)); 155.6 (C
(6)); 141.5 (C(3)); 128.4 (C(4)); 126.8 (C(1)); 124.5 (C(2));
109.7 (C(5)); 65.3 (C(10)); 56.9 (C(8)); 55.8 (MeO); 51.2
(C(9)); 34.2 (C(14)); 20.8 (C(12)); 19.1 (Me(15)); 19.0
(Me(16)); 16.2 (C(7)). ESI-MS: 345.17 ([M+Na]+).
3-(Acetyloxy)-2-hydroxy-2-(2-hydroxy-5-methoxy-4-met-
hylphenyl)propyl 2-methylpropanoate (3). 1H-NMR
(300 MHz, CDCl3): 6.68 (s, H–C(2)); 6.48 (s, H–C(5));
4.46 (dd, J = 22.4, 10.8, H–C(10), H–C(9)); 3.73 (s, MeO);
2.58 (m, H–C(14)); 2.15 (s, H–C(7)); 2.08 (s, H–C(12));
1.12 (d, J = 7.0, Me(15,16)). 13C-NMR (75 MHz, CDCl3):
177.5 (C(13)), 171.3 (C(11)), 151.2 (C(6)), 150.0 (C(3)),
126.5 (C(1)), 120.7 (C(4)), 118.8 (C(2)), 108.8 (C(5)), 78.5
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(C(8)), 67.4 (C(9)), 67.3 (C(10)), 56.3 (MeO), 34.1 (C
(14)), 20.9 (C(12)), 19.0 (Me(15,16)), 15.9 (C(7)). ESI-MS:
363.19 ([M+Na]+).
3,5-Dicaffeoylquinic Acid (= (3R,5R)-3,5-Bis{[(2E)-
3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4-dihydroxycy-
clohexanecarboxylic Acid; 4). 1H-NMR, 13C-NMR [44].
ESI-MS: 539.37 ([M+Na]+), 515.32 ([MH]).
1,3-Dicaffeoylquinic Acid (= (1R,3R,4S,5R)-1,3-Bis
{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihy-
droxycyclohexanecarboxylic Acid; 5). 1H-NMR, 13C-NMR
[45]. ESI-MS: 539.33 ([M+Na]+), 515.25 ([MH]).
3-Caffeoylquinic Acid (= Chlorogenic Acid; = (1R,3R,
4S,5R)-3-{[(2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoyl]oxy}-
1,4,5-trihydroxycyclohexanecarboxylic Acid; 6). 1H-NMR,
13C-NMR [46]. ESI-MS: 353.08 ([MH]), 377.17
([M+Na]+).
4-Caffeoylquinic Acid (= Criptochlorogenic Acid; =
(1S,3R,4S,5R)-4-{[(2E)-3-(3,4-Dihydroxyphenyl)prop-2-eno-
yl]oxy}-1,3,5-trihydroxycyclohexanecarboxylic Acid; 7).
1H-NMR, 13C-NMR [46]. ESI-MS: 353.19 ([MH]).
Caffeic Acid (= (2E)-3-(3,4-Dihydroxyphenyl)prop-2-
enoic Acid; 8). 1H-NMR, 13C-NMR [47]. ESI-MS: 178.98
([MH]), 203.02 ([M+Na]+).
Antioxidant Activity
DPPH free-radical scavenging activity was evaluated on a
microplate analytical assay according to the previously
described procedure by Srinivasan et al. [48]. A fresh
working solution of DPPH was prepared by dissolving
DPPH in EtOH to a final concentration of 100 lM. Incu-
bation with serial dilutions of essential oil, fractions and
isolated compounds was performed for 20 min at 37 °C in
the dark. Discoloration was measured at 517 nm using
the microplate reader FLUOstar Omega (BMG Labtech
GmbH, Ortenberg, Germany). The free-radical scaveng-
ing activity of each solution was then calculated as per-
cent inhibition according to the following equation:
% inhibition ¼ 100 ðAðblankÞ AðsampleÞÞ=AðblankÞ
Antioxidant activity of the essential oil, fractions, and
isolated compounds from S. sericea was expressed as IC50,
defined as the concentration of the test material required
to cause a 50% decrease in initial DPPH concentration.
Trolox was used as reference. Results are expressed in lM
Trolox equivalents (TE)/g of product.
The ABTS stock solution was prepared according to
the previously described procedure by Iqbal et al. [49].
ABTS (9.8 mg) was dissolved in 3.6 ml of distilled water
and manganese oxide (0.6 g) was added to the ABTS
solution and allowed to react for 20 min in the dark to
form the radical ABTS+. The stock solution was filtered
and the working solution was then obtained by diluting
ABTS+ stock solution in EtOH to reach a final solution
with absorbance of 0.700 OD at 734 nm. Trolox was used
as reference. Results are expressed in lM Trolox
equivalents (TE)/g of product. The capacity of free-radi-
cal scavenging (IC50) was determined using the same pre-
viously used equation for the DPPH method. All data of
antioxidant activity were expressed as means  standard
deviations (SD) of triplicate measurements.
The FRAP assay was performed on microplate
according to Firuzi et al. [50], with some modifications.
The stock solutions included 300 mM acetate buffer, pH
3.6, 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution in
40 mM HCl, and 20 mM FeCl3  6 H2O solution. The fresh
working solution was prepared by mixing 25 ml acetate
buffer, 2.5 ml TPTZ solution, and 2.5 ml FeCl3  6 H2O
solution and then warmed at 37 °C before using. Essential
oil, fractions, and isolated compounds from S. sericea
were allowed to react with FRAP solution for 30 min in
the dark. Readings of the colored product (ferrous
tripyridyltriazine complex) were then taken at 593 nm.
Trolox was used as reference. Results are expressed in lM
Trolox equivalents (TE)/g of product.
Cytotoxicity Assay
A375 (human malignant melanoma cells) and MDA-MB
231 cells (human breast adenocarcinoma cells) were cul-
tured in Dulbecco’s Modified Eagle’s Medium (DMEM)
with 2 mM L-glutamine, 100 IU/ml penicillin, 100 lg/ml
streptomycin, and supplemented with 10% heat-inacti-
vated fetal bovine serum (HI-FBS). HCT116 cells (human
colon carcinoma cells), were cultured in RPMI 1640
medium with 2 mM L-glutamine, 100 IU/ml penicillin,
100 lg/ml streptomycin, and supplemented with 10%
HI-FBS. Cells were cultured in a humidified atmosphere
at 37 °C in the presence of 5% CO2. The MTT assay was
used as a relative measure of cell viability. Cell viability
assays were carried out as described [51]. Briefly, cells
were seeded at the density of 2 9 104 cells/ml. After
24 h, samples were exposed to different concentrations of
essential oil (0.78 – 200 lg/ml) and isolated compounds
from polar fraction (0.19 – 25 lg/ml). Cells were incu-
bated for 72 h in a humidified atmosphere of 5% CO2
at 37 °C. At the end of incubation, each well received
10 ll of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetra-
zolium bromide (MTT) (5 mg/ml in phosphate-buffered
saline, PBS) and the plates were incubated for 4 h at
37 °C. The extent of MTT reduction was measured spec-
trophotometrically at 540 nm using a Titertek Multiscan
microElisa (Labsystems, Helsinki, Finland). Experiments
were conducted in triplicate. Cytotoxicity is expressed as
the concentration of compound inhibiting cell growth by
50% (IC50). The IC50 values were determined with
GraphPad Prism 4 computer program (GraphPad
Software, San Diego, CA, USA).
Antimicrobial Activity
Fraction, isolated compounds and essential oil were tested
against a panel of microorganisms including
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Staphylococcus aureus ATCC 25923, Escherichia coli
ATCC 25922, Pseudomonas aeruginosa ATCC 27853,
Enterococcus faecalis ATCC 29212, and Candida albicans
ATCC 24433. Bacterial strains were cultured overnight at
37 °C in blood agar plates. C. albicans was grown in
Sabouraud dextrose agar. Tests by the paper disk diffu-
sion method were performed following the Clinical and
Laboratory Standards Institute (CLSI) guidelines [52].
Briefly, a suspension of the tested microorganism
(1 – 2 9 108 cells per ml in saline-106 per ml for Can-
dida) was spread on the solid media plates using a sterile
cotton swab. Sterile paper discs (6 mm in diameter) were
placed on the surface of inoculated plates and spotted
with 10 ll of the essential oil and 1 mg of fractions and
isolated compounds dissolved in EtOH (1:1). The plates
were incubated 24 h at 35  1 °C (48 h for C. albicans).
The diameters of zone inhibition (including the 6 mm
disc) were measured with a caliper. A reading of more
than 6 mm indicated growth inhibition. No zone inhibi-
tion was observed using EtOH alone. Ciprofloxacin (5 lg
disc) and nystatin (100 Units disc) were used as reference
antimicrobials against bacteria and fungi, respectively.
Each test was repeated at least twice.
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